BCLI Form 10-Q: Quarterly report | BRAINSTORM CELL THERAPEUTICS INC.

BRAINSTORM CELL THERAPEUTICS INC. Form 10-Q: Quarterly report

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

2026-08-14: Form 10-Q; Period of report 2026-06-30; Description 10-Q; Document bcli-20260630x10q.htm.
2026-05-15: Form 10-Q; Period of report 2026-03-31; Description 10-Q; Document bcli-20260331x10q.htm.
2025-11-14: Form 10-Q; Period of report 2025-09-30; Description 10-Q; Document bcli-20250930x10q.htm.
2025-08-14: Form 10-Q; Period of report 2025-06-30; Description 10-Q; Document bcli-20250630x10q.htm.

Filed	Form	Period of report	Description	Document
2026-08-14	10-Q	2026-06-30	10-Q	bcli-20260630x10q.htm
2026-05-15	10-Q	2026-03-31	10-Q	bcli-20260331x10q.htm
2025-11-14	10-Q	2025-09-30	10-Q	bcli-20250930x10q.htm
2025-08-14	10-Q	2025-06-30	10-Q	bcli-20250630x10q.htm
2025-05-15	10-Q	2025-03-31	10-Q	bcli-20250331x10q.htm
2024-11-14	10-Q	2024-09-30	10-Q	bcli-20240930x10q.htm
2024-08-14	10-Q	2024-06-30	10-Q	bcli-20240630x10q.htm
2024-05-14	10-Q	2024-03-31	10-Q	bcli-20240331x10q.htm
2023-11-14	10-Q	2023-09-30	10-Q	bcli-20230930x10q.htm
2023-08-14	10-Q	2023-06-30	10-Q	bcli-20230630x10q.htm
2023-05-15	10-Q	2023-03-31	10-Q	bcli-20230331x10q.htm
2022-11-14	10-Q	2022-09-30	10-Q	bcli-20220930x10q.htm
2022-08-15	10-Q	2022-06-30	10-Q	bcli-20220630x10q.htm
2022-05-16	10-Q	2022-03-31	10-Q	bcli-20220331x10q.htm
2021-11-15	10-Q	2021-09-30	10-Q	bcli-20211030x10q.htm
2021-08-05	10-Q	2021-06-30	FORM 10-Q	bcli-20210630x10q.htm
2021-04-26	10-Q	2021-03-31	FORM 10-Q	bcli-20210331x10q.htm
2020-10-15	10-Q	2020-09-30	FORM 10-Q	bcli-20200930x10q.htm
2020-08-05	10-Q	2020-06-30	FORM 10-Q	bcli-20200630x10q.htm
2020-05-07	10-Q	2020-03-31	FORM 10-Q	tm2014563d1_10q.htm
2019-11-14	10-Q	2019-09-30	FORM 10-Q	tm1919513-1_10q.htm
2019-08-13	10-Q	2019-06-30	FORM 10-Q	tv526318_10q.htm
2019-05-10	10-Q	2019-03-31	FORM 10-Q	tv520507_10q.htm
2018-10-29	10-Q	2018-09-30	10-Q	tv505023_10q.htm
2018-07-23	10-Q	2018-06-30	FORM 10-Q	tv498184_10q.htm
2018-05-14	10-Q	2018-03-31	FORM 10-Q	tv491824_10q.htm
2017-10-17	10-Q	2017-09-30	FORM 10-Q	v475447_10q.htm
2017-08-14	10-Q	2017-06-30	FORM 10-Q	v472033_10q.htm
2017-05-15	10-Q	2017-03-31	FORM 10-Q	v466042_10q.htm
2016-11-14	10-Q	2016-09-30	FORM 10-Q	v451301_10q.htm
2016-08-11	10-Q	2016-06-30	FORM 10-Q	v445016_10q.htm
2016-05-10	10-Q	2016-03-31	FORM 10-Q	v437577_10q.htm
2015-11-16	10-Q	2015-09-30	FORM 10-Q	v423105_10q.htm
2015-08-13	10-Q	2015-06-30	FORM 10-Q	v416801_10q.htm
2015-05-14	10-Q	2015-03-31	FORM 10-Q	v409490_10q.htm
2014-11-13	10-Q	2014-09-30	10-Q	v392478_10q.htm
2014-08-12	10-Q	2014-06-30	FORM 10-Q	v385077_10q.htm
2014-05-13	10-Q	2014-03-31	10-Q	v376739_10q.htm
2013-11-14	10-Q	2013-09-30	10-Q	v357929_10q.htm
2013-08-14	10-Q	2013-06-30	10-Q	v349900_10q.htm
2013-05-09	10-Q	2013-03-31	10-Q	v342541_10q.htm
2012-11-13	10-Q	2012-09-30	FORM 10-Q	v325978_10q.htm
2012-08-13	10-Q	2012-06-30	FORM 10-Q	v319342_10q.htm
2012-05-11	10-Q	2012-03-31	10-Q	v311796_10q.htm
2011-11-14	10-Q	2011-09-30	10-Q	v238795_10q.htm
2011-08-15	10-Q	2011-06-30	FORM 10-Q	v231506_10q.htm
2011-05-13	10-Q	2011-03-31	Quarterly report	v222233_10q.htm
2010-11-15	10-Q	2010-09-30	Quarterly report	v201996_10q.htm
2010-08-16	10-Q	2010-06-30	Quarterly report	v193804_10q.htm
2010-05-17	10-Q	2010-03-31	Quarterly report	v185296_10q.htm
2009-11-16	10-Q	2009-09-30	Quarterly report	v166440_10q.htm
2009-08-19	10-Q	2009-06-30	Quarterly report	v158656_10q.htm
2009-05-14	10-Q	2009-03-31	Quarterly report	v149130_10q.htm
2008-11-19	10-Q	2008-09-30	Quarterly report	v132726_10q.htm
2008-08-13	10-Q	2008-06-30	Quarterly report	v123129_10q.htm
2008-05-15	10-Q	2008-03-31	Quarterly report	v114422_10q.htm

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
INTENSITY THERAPEUTICS, INC. (INTS)	United States	$0.013B	-1.08
Pluri Inc. (PLUR)		$0.014B
IN8BIO, INC. (INAB)	United States	$0.012B	-0.76
Senti Biosciences Holdings, Inc. (SNTI)	United States	$0.011B	-0.70
Passage BIO, Inc. (PASG)	United States	$0.015B	-0.43
DYADIC INTERNATIONAL INC (DYAI)	United States	$0.016B
BioCardia, Inc. (BCDA)	United States	$0.016B
TScan Therapeutics, Inc. (TCRX)	United States	$0.008B	-1.23
CERO THERAPEUTICS HOLDINGS, INC. (CERO)	United States	$0.007B
Jasper Therapeutics, Inc. (JSPR)	United States	$0.020B	-0.37